Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Several other weight-loss pills are also in late-stage trials ... People taking the GLP-1 mimics for diabetes have also been found to have a lower risk of 10 different cancers that are linked with ...

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...

In an interview with Peers & Perspectives in Oncology, Sherry Shen, MD, discusses the GLP-1 agonists analyzed for weight ...

That's why we made it our mission to identify the absolute best cortisol supplements on the market in 2024. We've analyzed ...

While both berberine and Ozempic may lead to weight loss, they are very different things. It’s “inaccurate and misleading” to ...

Women have always longed to feel powerful like the men! While women are breaking all the stereotypes in the business world and have begun to bear the financially independent flag all around the world; ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are ...

Also, Sen. Bernie Sanders spoke up again about Ozempic's manufacturer Novo Nordisk, alleging that it can make and sell its weight loss drug for under $100 a month. Meanwhile, CNN notes that GLP-1 ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...